Rheumatoid arthritis-associated interstitial lung disease hotspots and future directions: A Web-of-Science based scientometric and visualization study.
iInterstitial lung disease
pathogenesis
predictive and prognostic factors
rheumatoid arthritis
treatment
visualization
Journal
Immunity, inflammation and disease
ISSN: 2050-4527
Titre abrégé: Immun Inflamm Dis
Pays: England
ID NLM: 101635460
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
27
06
2023
received:
30
03
2023
accepted:
06
07
2023
medline:
1
9
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
ppublish
Résumé
To identify new trends and potential hotspots in research on rheumatoid arthritis-associated interstitial lung disease (RA-ILD). The Web of Science (WOS) database was used to search for RA-ILD-related literature published between August 31, 2002 and August 31, 2022. CiteSpace 6.1.R3, VOSviewer version 1.6.17, Scimago Graphica, and Pajek V2.0 visualization software were used to conduct a comprehensive analysis and network visualization mapping of the authors, countries, institutions, journals, cited references, and keywords. A total of 2412 articles were retrieved, and the number of articles published has grown annually since 2002. Eric L. Matteson was the most prolific author, and the Mayo Clinic and UNITED STATES have the highest publishing volume and influence. Clinical Rheumatology is the journal with the most papers published. Rheumatology was the most cited journal. The citation clusters and keywords concentrated on the mechanism, treatment, and predictive and prognostic factors. Pathogenesis, treatment, and predictive and prognostic factors were among the RA-ILD research directions and hotspots. Antirheumatoid drugs, especially biologics and small molecule inhibitors, were among the most actively researched treatment options. The results of this study provides an in-depth understanding of the development of RA-ILD publications, aids researchers in understanding hotspots and trends and provides a new perspective for future RA-ILD research.
Identifiants
pubmed: 37647438
doi: 10.1002/iid3.944
pmc: PMC10461424
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e944Informations de copyright
© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Références
Ann Rheum Dis. 2021 Dec;80(12):1530-1536
pubmed: 34344703
Clin Rheumatol. 2021 Nov;40(11):4533-4543
pubmed: 34189672
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1403-12
pubmed: 25822095
J Rheumatol. 2016 May;43(5):855-60
pubmed: 26980577
Clin Rheumatol. 2021 Dec;40(12):4861-4867
pubmed: 34313866
Arthritis Res Ther. 2021 Aug 14;23(1):212
pubmed: 34391465
Eur Respir J. 2019 Jan 3;53(1):
pubmed: 30487199
Eur Respir J. 2019 Apr 11;53(4):
pubmed: 30635297
Ther Adv Respir Dis. 2017 Jan;11(1):64-72
pubmed: 27733490
Eur Respir J. 2010 Jun;35(6):1322-8
pubmed: 19996193
Arthritis Rheum. 2010 Jun;62(6):1583-91
pubmed: 20155830
Intern Med J. 2020 Mar;50(3):330-336
pubmed: 30963656
Eur Respir J. 2021 Feb 11;57(2):
pubmed: 32646919
Case Rep Med. 2021 Apr 22;2021:6652845
pubmed: 33976699
Front Med (Lausanne). 2022 Jul 29;9:931626
pubmed: 35966862
Semin Arthritis Rheum. 2018 Aug;48(1):22-27
pubmed: 29422324
Arthritis Rheumatol. 2015 Jan;67(1):28-38
pubmed: 25302945
Ann Rheum Dis. 2017 Oct;76(10):1700-1706
pubmed: 28611082
Curr Opin Pulm Med. 2018 May;24(3):269-280
pubmed: 29474209
FASEB J. 2022 Jun;36(6):e22336
pubmed: 35522243
BMJ Open. 2019 May 5;9(5):e028466
pubmed: 31061059
Lancet Respir Med. 2016 Sep;4(9):708-719
pubmed: 27469583
Lancet Respir Med. 2017 Nov;5(11):869-880
pubmed: 29066090
Clin Rheumatol. 2019 Apr;38(4):1201-1206
pubmed: 30645754
N Engl J Med. 2018 Dec 6;379(23):2209-2219
pubmed: 30345907
Neural Regen Res. 2019 Sep;14(9):1643-1650
pubmed: 31089065
Arthritis Rheumatol. 2014 Apr;66(4):803-12
pubmed: 24757133
Inflammopharmacology. 2022 Jun;30(3):705-712
pubmed: 35462572
Arthritis Rheum. 1996 Oct;39(10):1711-9
pubmed: 8843862
Arthritis Rheumatol. 2014 Jan;66(1):31-9
pubmed: 24449573
Rheumatol Ther. 2021 Sep;8(3):1435-1441
pubmed: 34184191
Front Med (Lausanne). 2021 Nov 23;8:787228
pubmed: 34888333
Front Mol Biosci. 2022 Jan 13;8:797902
pubmed: 35096970
Mod Rheumatol. 2021 Jan;31(1):13-19
pubmed: 32964766
Ann Rheum Dis. 2003 Aug;62(8):722-7
pubmed: 12860726
Semin Arthritis Rheum. 2011 Oct;41(2):256-64
pubmed: 21277618
Rheumatology (Oxford). 2012 Mar;51(3):578-80
pubmed: 22116998
BMJ Open. 2013 Sep 13;3(9):e003132
pubmed: 24038004
Rheumatology (Oxford). 2017 Aug 1;56(8):1348-1357
pubmed: 28444364
Rheumatology (Oxford). 2007 Jan;46(1):70-5
pubmed: 16782731
Rheumatology (Oxford). 2009 Sep;48(9):1069-72
pubmed: 19321513
J Clin Rheumatol. 2021 Dec 1;27(8):e482-e490
pubmed: 32826657
Semin Arthritis Rheum. 2014 Apr;43(5):613-26
pubmed: 24231065
Respir Res. 2021 Oct 11;22(1):264
pubmed: 34635095
Respiration. 2019;98(5):455-460
pubmed: 31597131
Respirology. 2014 May;19(4):493-500
pubmed: 24372981
Rheumatol Ther. 2021 Mar;8(1):517-527
pubmed: 33586127
Eur Respir J. 2016 Feb;47(2):588-96
pubmed: 26585429
Ann Rheum Dis. 2020 Jun;79(6):685-699
pubmed: 31969328
Am J Respir Crit Care Med. 2011 Feb 1;183(3):372-8
pubmed: 20851924
Curr Probl Cardiol. 2022 Sep;47(9):101243
pubmed: 35545178
Ann Rheum Dis. 2011 Dec;70(12):2148-51
pubmed: 21852254
Rheumatology (Oxford). 2014 Sep;53(9):1676-82
pubmed: 24758887
N Engl J Med. 2019 Oct 31;381(18):1718-1727
pubmed: 31566307